ISRG: The Entry We've Been Waiting For

The Aging of Society & Medical Innovation theme is one of the most durable secular investment opportunities in the global economy. As populations age and life expectancy continues to rise, demand for orthopedic procedures, cancer treatments, cardiovascular interventions, and minimally invasive surgeries is expected to increase for decades. Rather than investing solely in pharmaceutical companies, this theme focuses on the technologies that enable better patient outcomes—medical devices, robotic-assisted surgery, diagnostics, and precision medicine. These businesses benefit from powerful demographic tailwinds, high barriers to entry, recurring procedure-driven revenue, and long product lifecycles, creating an attractive combination of durable earnings growth and resilient cash flow. At the center of this theme is Intuitive Surgical (ISRG), the global leader in robotic-assisted surgery. With thousands of da Vinci systems installed worldwide, Intuitive has built an ecosystem that extends far beyond selling robots. Every new procedure generates recurring revenue through instruments, accessories, software, service contracts, and system upgrades, while hospitals and surgeons become increasingly embedded in its platform. As robotic surgery expands into new specialties and international markets, Intuitive is positioned to benefit from rising procedure volumes for years to come. For long-term investors, it represents a unique combination of demographic growth, technological leadership, recurring revenue, and a wide competitive moat—making it one of the highest-quality ways to invest in the future of healthcare.